Form 4 for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE
Accepted 2024-09-17 00:00:00 ET · period of report 2024-09-13 · accession 0001801170-24-000190 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-09-17 | 2024-09-13+ | CLOV | Reynoso Jamie L. | CEO, Medicare Advantage | F - Tax | $2.99 | -123.2K | 2.78M | -4% | -$368.3K |
| 2024-09-17 | 2024-09-13 | CLOV | Reynoso Jamie L. | CEO, Medicare Advantage | A - Grant | $0.00 | +259.0K | 2.88M | +10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-09-14 | F | D | 12,567 | $2.99 | 2,763,136 | D | — | — | (F3) Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on September 14, 2024, of 6.25% of RSUs granted to the Reporting Person on March 14, 2022, and originally reported on a Form 4 filed on March 16, 2022. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on March 14, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date. |
| 2 | Common | Class A Common Stock | 2024-09-15 | F | D | 8,691 | $2.99 | 2,754,445 | D | — | — | (F4) Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on September 15, 2024, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on September 16, 2022, and originally reported on a Form 4 filed on September 20, 2022. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on September 16, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date. |
| 3 | Common | Class A Common Stock | 2024-09-13 | F | D | 101,917 | $2.99 | 2,775,703 | D | — | — | (F2) Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of 1/2 of the number of earned performance-based restricted stock units, as described above. |
| 4 | Common | Class A Common Stock | 2024-09-13 | A | A | 259,000 | $0.00 | 2,877,620 | D | — | — | (F1) Represents restricted stock units ("RSUs"), each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on October 31, 2023. One-half of the number of earned restricted stock units vested and were settled on September 13, 2024, and the remaining one-half of the restricted stock units will vest on October 31, 2025, subject to the Reporting Person's continued employment on such vesting date. |